Title : Novel targeted therapies in inflammatory breast cancer.

Pub. Date : 2010 Jun 1

PMID : 20503416






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Another chemotherapeutic drug, lapatinib, a dual tyrosine inhibitor of epidermal growth factor (EGFR) and HER2 signaling, in combination with capecitabine demonstrated encouraging results, with a 51% decrease in disease progression. Tyrosine epidermal growth factor Homo sapiens
2 Another chemotherapeutic drug, lapatinib, a dual tyrosine inhibitor of epidermal growth factor (EGFR) and HER2 signaling, in combination with capecitabine demonstrated encouraging results, with a 51% decrease in disease progression. Tyrosine epidermal growth factor Homo sapiens